TLS Online TPP Program

#Question id: 3555


In watermelons, bitter fruit (B) is dominant over sweet fruit (b), and yellow spots (S) are dominant over no spots (s). The genes for these two characteristics assort independently. A homozygous plant that has bitter fruit and yellow spots is crossed with a homozygous plant that has sweet fruit and no spots. If an F1 plant is cross with the heterozygous for bitter and no spots, what phenotypes ratio are expected in the offspring?

#SCPH12 I Genetics
  1. 9:3:3:1               

  2. 1:1:1:1            

  3. All bitter fruit and yellow spots             

  4. 3: 1:3:1

More Questions
TLS Online TPP Program

#Question id: 1405

#SCPH28 | Zoology

A gain-of-function mutation in which of the following would have the same effect as a gain-of-function mutation in Ras?

TLS Online TPP Program

#Question id: 1406

#SCPH05 I Biotechnology

Which of the following is a consequence of p53 stabilization?

a. stabilization of Cdc25A      b. activation of ATM                c. blocked apoptosis

d. transcription of p21                        e. DNA repair

TLS Online TPP Program

#Question id: 1406

#SCPH06 I Botany

Which of the following is a consequence of p53 stabilization?

a. stabilization of Cdc25A      b. activation of ATM                c. blocked apoptosis

d. transcription of p21                        e. DNA repair

TLS Online TPP Program

#Question id: 1406

#SCPH28 | Zoology

Which of the following is a consequence of p53 stabilization?

a. stabilization of Cdc25A      b. activation of ATM                c. blocked apoptosis

d. transcription of p21                        e. DNA repair

TLS Online TPP Program

#Question id: 1407

#SCPH05 I Biotechnology

Which of the following is pro-apoptotic?

a. Bax              b. Bcl-2                       c. p53              d. protein kinase B      e. PTEN

TLS Online TPP Program

#Question id: 1407

#SCPH06 I Botany

Which of the following is pro-apoptotic?

a. Bax              b. Bcl-2                       c. p53              d. protein kinase B      e. PTEN